Pharmacoeconomic analysis of adjuvant therapy with exemestane anastrozole letrozole or tamoxifen in postmenopausal women with operable and estrogen receptor-positive breast cancer
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.